Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $18,182 | 1 | 70.3% |
| Consulting Fee | $6,294 | 3 | 24.3% |
| Food and Beverage | $1,376 | 16 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $18,216 | 3 | $0 (2023) |
| Janssen Research & Development, LLC | $4,290 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $1,329 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $924.93 | 4 | $0 (2024) |
| Celgene Corporation | $254.75 | 3 | $0 (2024) |
| SOBI, INC | $151.22 | 1 | $0 (2024) |
| Eli Lilly and Company | $148.07 | 1 | $0 (2019) |
| Kite Pharma, Inc. | $147.10 | 2 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $125.00 | 1 | $0 (2017) |
| Incyte Corporation | $124.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $456.34 | 4 | SOBI, INC ($151.22) |
| 2023 | $19,014 | 5 | Genentech, Inc. ($18,182) |
| 2022 | $1,783 | 6 | E.R. Squibb & Sons, L.L.C. ($1,329) |
| 2021 | $4,290 | 1 | Janssen Research & Development, LLC ($4,290) |
| 2019 | $148.07 | 1 | Eli Lilly and Company ($148.07) |
| 2018 | $34.52 | 2 | Genentech, Inc. ($34.52) |
| 2017 | $125.00 | 1 | Jazz Pharmaceuticals Inc. ($125.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $151.22 | General |
| Category: HEMATOLOGY | ||||||
| 08/21/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $64.92 | General |
| Category: Heart Failure | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $115.32 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $124.88 | General |
| 12/04/2023 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: CELLT | ||||||
| 09/29/2023 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 08/06/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $60.44 | General |
| Category: Oncology | ||||||
| 06/30/2023 | Genentech, Inc. | — | Grant | Cash or cash equivalent | $18,181.82 | General |
| 05/30/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | KYMRIAH (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 12/30/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,329.00 | General |
| 12/12/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $117.99 | General |
| 12/12/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| 07/27/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 05/10/2022 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Oncology | ||||||
| 02/17/2022 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $74.17 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2021 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $4,290.00 | General |
| 03/08/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $148.07 | General |
| 03/28/2018 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $19.39 | General |
| 03/28/2018 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $15.13 | General |
| 07/31/2017 | Jazz Pharmaceuticals Inc. | Defitelio (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 175 | $58,706 | $19,726 |
| 2022 | 4 | 56 | 207 | $72,486 | $21,495 |
| 2021 | 1 | 14 | 149 | $75,245 | $14,131 |
| 2020 | 1 | 16 | 92 | $45,540 | $8,874 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 135 | $50,319 | $14,541 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 40 | $8,387 | $5,185 | 61.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 148 | $54,464 | $13,771 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 36 | $5,680 | $4,569 | 80.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $7,436 | $1,984 | 26.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 12 | $4,906 | $1,170 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 149 | $75,245 | $14,131 | 18.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 92 | $45,540 | $8,874 | 19.5% |
About Dr. Melody Smith, MD
Dr. Melody Smith, MD is a Internal Medicine healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1790915031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melody Smith, MD has received a total of $25,851 in payments from pharmaceutical and medical device companies, with $456.34 received in 2024. These payments were reported across 20 transactions from 12 companies. The most common payment nature is "Grant" ($18,182).
As a Medicare-enrolled provider, Smith has provided services to 135 Medicare beneficiaries, totaling 623 services with total Medicare billing of $64,225. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Medical Oncology
- Location Stanford, CA
- Active Since 07/21/2009
- Last Updated 04/16/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790915031
Products in Payments
- KYMRIAH (Drug) $850.76
- GAMIFANT (Drug) $151.22
- Defitelio (Drug) $125.00
- MONJUVI (Drug) $124.99
- KYMRIAH (Biological) $74.17
- CARDIOMEMS (Device) $64.92
- Yescarta (Drug) $22.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stanford
Dr. Christian Eversull, M.d, M.D
Internal Medicine — Payments: $2.9M
Glenn Chertow, Md, MD
Internal Medicine — Payments: $1.9M
Rahul Sharma, Md, MD
Internal Medicine — Payments: $1.0M
Deepu Madduri, Md, MD
Internal Medicine — Payments: $749,916
Mark Pegram, M.d, M.D
Internal Medicine — Payments: $542,122
Richard Lafayette, M.d, M.D
Internal Medicine — Payments: $499,103